ARCHIVES

Biotheraputices To Reveal Plans for Expansion

This article is from The Cancer Letter archive.

Vol. 12 No. 32 | August 8, 1986

Download PDF Visit The Full Archive

Related Articles

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

NCI RFAs Available

May 5, 2000

Study tests a “truth” in radiation oncology, raises questions about anemia treatment.

October 24, 2003

Study Opens For Women At Risk of Ovarian Cancer

October 29, 2004

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997

Risk of Lymphoma Increases with Hepatitis C Virus Infection

May 25, 2007